At Charles River, we are incredibly proud of our work in #cancerresearch. We worked on 87% of all oncology drugs approved by the U.S. FDA in 2023. Throughout the month of September we will be sharing the impact of our work during #Oncology Awareness Month.
Charles River Laboratories
Biotechnology Research
Wilmington, Massachusetts 191,142 followers
Together, We Create Healthier Lives
Über uns
At Charles River, we are passionate about our role in improving the quality of people’s lives. Our mission, our excellent science and our strong sense of purpose guides us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well-being of many across the globe. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL
- Website
-
http://criver.com
External link for Charles River Laboratories
- Industrie
- Biotechnology Research
- Größe des Unternehmens
- 10.001+ Mitarbeiter
- Hauptsitz
- Wilmington, Massachusetts
- Typ
- Öffentliches Unternehmen
- Gegründet
- 1947
- Spezialitäten
- Research Models & Services, Preclinical Services, Discovery Research Services, Biologics Testing Solutions, Microbial Identificiation, Endotoxin Testing, LAL, Early Discovery, Safety Testing, and Agrochemical
Standorte
-
Primäre
251 Ballardvale Street
Wilmington, Massachusetts 01887, US
Employees at Charles River Laboratories
-
Tracy Vachon
-
Michelle Berthiaume
Senior Director Global Change Management at Charles River Laboratories
-
Nick Hong
Associate Director, Global Categories Procurement at Charles River Laboratories
-
Tim DiMacchia, MBA
A results-oriented executive with a proven track record in driving technological excellence and innovation.
Aktualisierungen
-
Digital #pathology is key to putting your #drugdevelopment program in the fast lane in your race from research to market. Explore how #pathologists can do more in less time, leveraging the latest in digitization and AI-support to streamline workflows and gain deeper insights, enabling you to bring better treatments to patients faster. https://okt.to/jTkL57
-
Screening your #chemical compound doesn’t have to be costly and time consuming. Ames and #micronucleus screening provide a rapid turnaround time at low costs while predicting risks in your compound. Watch the full webinar to gain insights on how predictive screening identifies your compound’s red flags early. https://okt.to/J1vRoZ
-
Modelling myelination in vitro is difficult due to the complexities of isolating and culturing primary oligodendrocyte. In this poster to be presented at #Neuroscience 2024, our scientists will outline an iPSC-derived model of myelination, with co-culture of oligodendrocytes and neurons, for use in multiple sclerosis drug discovery. https://okt.to/P0I7mV #SfN24 #multiplesclerosis #drugdiscovery
-
Discover how Priority Review Vouchers can significantly impact healthcare by accelerating access to life-saving treatments. An important US government program is on the chopping block September 30. Learn more at https://okt.to/FYqzKM
How Priority Review Vouchers Can Save Lives | Charles River
-
The local chapter of our Emotional Health & Wellness ERG in #Charleston, South Carolina collected three boxes worth of various school supplies items that they donated to a local school: W.B. Goodwin Elementary! Kelsey T. commented, "It was extremely uplifting and such a good feeling to see their reactions to our donations." Way to go team! #LIFEatCRL
-
-
Reflecting on #BIO2024, one of the highlights was the collaboration that went on during our visual map activity! Thank you all for contributing your insights and challenges on building momentum in the drug development journey and helping us create our unique visual map. If you missed our visual map activity or want to view the full visual map with key takeaways, check it out here: https://okt.to/q7rTUn
BIO 2024 Visual Map: The Drug Development Journey
-
Are you ready to hit the ground running in a new #career? This is your moment. #careerdevelopment #jobopportunity
-
-
How researchers are using structural information and in silico modelling applications to improve the accuracy of #bifunctional protein degraders. Learn more about this on our Eureka Blog: https://okt.to/Qn69G1
Fine-Tuning Targeted Protein Degraders | Charles River
criver.com
-
“To build a purpose-built facility that reduces timelines, utilizing data to drive decisions.” Our Kansas facility was built with accelerating your program in mind, while also reducing how we work with animals in research in support of the 3R principles. https://okt.to/eDm3qy